SAN FRANCISCO, Nov. 30, 2015 (GLOBE NEWSWIRE) -- BioQ Pharma, a specialty pharmaceutical company focused on the development and commercialization of large volume ready-to-use infusible pharmaceuticals, announced today that the Company will be presenting at the 26th Annual Oppenheimer Healthcare Conference to be held in New York City on December 8th and 9th, 2015.
Josh Kriesel, President and Chief Executive Officer, is scheduled to present on Tuesday, December 8th at 2:45 p.m. Eastern Standard Time.
About the Company: BioQ Pharma is a privately held specialty pharmaceutical company focused on developing and commercializing ready-to-use infusible pharmaceuticals. The Company's infusion platform is intended to address some of the most pressing unmet needs in drug infusion today: cost, medication error, sterility, efficiency, and patient quality of life. BioQ Pharma's vision is to set a new standard of care in the presentation and administration of infusible pharmaceuticals via the Company's proprietary unit-dose infusion systems that can be deployed quickly and conveniently at the point of care with one touch. The Company is ISO13485 certified. BioQ Pharma's commercial collaborators and strategic partners include Novartis' Sandoz unit, Cipla, Lee's Pharmaceutical and West Pharmaceutical Services.
CONTACT: BioQ Pharma Contact Information: Josh Kriesel President and CEO 415-336-6496 Ron Pauli Chief Financial Officer 415-889-7707 Media: Stephanie Carrington Integrated Corporate Relations, Inc (ICR) firstname.lastname@example.org 646-277-1282
Source: BioQ Pharma